Please provide your email address to receive an email when new articles are posted on . CHICAGO — A sequential schedule of fixed-dose pembrolizumab with chemoradiotherapy conferred numerically higher ...
RESULTS: Concurrent radiotherapy yielded better survival than sequential radiotherapy (P = .097 by log-rank test). The median survival time was 19.7 months in the sequential arm versus 27.2 months in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results